小剂量氨磺必利与利培酮治疗对女性SCH患者IL-18、IL-1β及不良反应的影响
DOI:
作者:
作者单位:

永新县第三人民医院

作者简介:

通讯作者:

中图分类号:

基金项目:


Influence of low-dose amisulpride and risperidone on IL-18, IL-1β and adverse reactions in female patients with SCH
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    目的:观察小剂量氨磺必利与利培酮对女性精神分裂症(SCH)患者白介素-18(IL-18)白介素-1β(IL-1β)及不良反应的影响。方法:选取2022年1月-2024年11月我院接诊的62例女性SCH患者,按照随机掷硬币法分为单一组(31例,给予利培酮治疗)和联合组(31例,在单一组基础上给予小剂量氨磺必利),连续治疗1个月。对比观察两组女性SCH患者的症状[阳性与阴性症状量表(PANSS)]、记忆及认知功能[龚氏成人记忆量表(WMS-RC)、简易智力状态量表(MMSE)]、心电图指标、炎症因子及不良反应。结果:较同组治疗前,两组患者治疗1个月后的PANSS各维度评分均更低且联合组低于单一组(P<0.05);治疗1个月后,两组WMS-RC、MMSE评分均较治疗前更高(P<0.05),但联合组与单一组上述得分相比差异无统计学意义(P>0.05);较同组治疗前,两组患者治疗1个月后QTc间期延长但联合组短于单一组(P<0.05);两组患者治疗1个月后的IL-18、IL-1β水平均低于同组治疗前且联合组低于单一组(P<0.05);两组患者不良反应(失眠、激越、低血压、体质量指数增加、月经紊乱)总发生率,差异无统计学意义(P>0.05)。结论:小剂量氨磺必利联合利培酮能改善女性SCH患者症状,提高记忆力及认知功能,减轻炎症反应,改善心功能,且安全性较好。

    Abstract:

    Objective: To observe the influence of low-dose amisulpride and risperidone on interleukin-18 (IL-18), interleukin-1β (IL-1β) and adverse reactions in females with schizophrenia (SCH). Methods: A total of 62 female patients with SCH in the hospital were selected from January 2022 to November 2024, and were divided into single group (31 cases, risperidone) and combined group (31 cases, low-dose amisulpride on the basis of single group) according to the random coin tossing method. Both groups were continuously treated for 1 month. The symptoms [Positive and Negative Syndrome Scale (PANSS)], memory and cognitive function [Chinese Wechsler Memory Scale-revised (WMS-RC), Mini-Mental State Examination (MMSE)], electrocardiographic indicators, inflammatory factors and adverse reactions in the two groups of female SCH patients were compared and observed. Results: Compared with before treatment, the scores of dimensions of PANSS in the two groups of patients were lower after 1 month of treatment, and the scores in combined group were lower than those in single group (P<0.05). After 1 month of treatment, the WMS-RC score and MMSE score in both groups were higher than those before treatment (P<0.05), but there were no statistical differences in the above scores between combined group and single group (P>0.05). Compared with before treatment, the QTc interval in the two groups was prolonged after 1 month of treatment, but the QTc interval in combined group was shorter than that in single group (P<0.05). The levels of IL-18 and IL-1β in the two groups after 1 month of treatment were lower than those before treatment, and the levels in combined group were lower than those in single group (P<0.05). There was no statistical significance in the total incidence rate of adverse reactions (insomnia, agitation, hypotension, increased body mass index, menstrual disorders) between the two groups (P>0.05). Conclusion: Low-dose amisulpride combined with risperidone can improve the symptoms of female patients with SCH, enhance the memory and cognitive function, relieve the inflammatory response, and improve the cardiac function, and has good safety.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2025-05-26
  • 最后修改日期:2025-06-24
  • 录用日期:2025-07-02
  • 在线发布日期:
  • 出版日期: